Jeremy Little

Jeremy Little has a diverse work experience spanning over two decades. Jeremy started their career at Millennium Pharmaceuticals as a Scientist I/II in Medicinal Chemistry and worked there for five years. Jeremy then joined Pfizer Pharmaceuticals, where they held positions as a Principal Scientist and later as a Senior Principal Scientist. In 2012, Jeremy became the Vice President of North American Affairs at BioSpring GmbH, a position they held until 2016. After that, they worked as a Business Development Manager at Innovassynth Technologies(I) LTD. for a year. Jeremy then joined AnaSpec as a Business Development Manager for the East Coast region. Currently, they are the Director of the Oligonucleotide Business Unit at ChemGenes, a position they have held since 2019.

Jeremy Little earned their Bachelor of Science degree in Chemistry from Worcester Polytechnic Institute, where they attended from 1991 to 1995. Jeremy then pursued further education at the University of Michigan from 1998 to 2000, focusing on Organic Chemistry. Finally, they completed their Doctor of Philosophy (Ph.D.) in Organic Chemistry at the University of Wisconsin-Madison from 1995 to 2001.